When did Odyssey Therapeutics Inc go public?

Odyssey Therapeutics Inc completed its IPO on May 8, 2026 on NASDAQ Capital under the ticker ODTX and now trades publicly.

What was Odyssey Therapeutics Inc's IPO price?

Odyssey Therapeutics Inc priced its IPO at $18.00 per share.

Can I buy Odyssey Therapeutics Inc stock?

Yes — Odyssey Therapeutics Inc is publicly traded on NASDAQ Capital as ODTX. You can follow its live price, valuation and post-IPO performance above.

What is Odyssey Therapeutics Inc's valuation?

Odyssey Therapeutics Inc's most recent valuation tracked here is $1.03B, derived from live market prices.

All companies

Odyssey Therapeutics Inc

ODTX

PublicArchived

Public / ArchivedUnited States(NASDAQ Capital)Best valuation $1.03BSince IPO +19.00%1 market

Public listing

Listed· NASDAQ Capital· Listing market: United States

Listing date

May 8, 2026

Final IPO price

$18.00

Shares offered

15,500,000

Offering proceeds

$279M

Sources: sec-harvest, nasdaq

IPO Calendar · NASDAQIPO

ODTX

Price

$21.42

24h

+2.54%

Valuation

$1.03B

24h volume

$2.75M

Type

IPO

Trade Odyssey Therapeutics Inc

Now trading publicly. Buy via a broker — opens in a new tab.

Trade on IPO Calendar

IPO Calendar · updated 2h ago

About Odyssey Therapeutics Inc

Odyssey Therapeutics Inc is a healthcare and life-sciences company with a business profile centered on medical products, therapies, diagnostics, or health-related services.

What the company does

Develops healthcare products, therapies, devices, or services where clinical evidence and regulatory execution are central to the business.
Operates in a market shaped by product differentiation, development timelines, reimbursement or customer adoption, and disciplined capital allocation.
Relies on technical, clinical, commercial, and operational teams to move products from development toward broader use.

Business profile

Odyssey Therapeutics Inc belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.

SEC IPO filings

Final prospectus

EDGAR filings resolved from ODTX / CIK 0001882782.

424B4424B4

May 8, 2026Final prospectus0001193125-26-214819

EFFECTxslEFFECTX01/primary_doc.xml

May 7, 2026Effective9999999995-26-001538

CERTODTX_8A_Cert_1882782.pdf

May 7, 2026Exchange registration0001354457-26-000416

8-A12B8-A12B

May 5, 2026Exchange registration0001193125-26-205798

S-1/AS-1/A

May 4, 2026Amended0001193125-26-202398

S-1S-1

Apr 17, 2026Filed0001193125-26-161514

DRS/Afilename1.htm

Apr 3, 2026Confidential draft0001193125-26-142305

DRS/Afilename1.htm

Mar 16, 2026Confidential draft0001193125-26-108608

DRSfilename1.htm

Feb 6, 2026Confidential draft0001193125-26-041396

RWRW

Jun 9, 2025Withdrawn0001193125-25-137861

S-1S-1

Jan 17, 2025Filed0001193125-25-008362

DRS/Afilename1.htm

Dec 5, 2024Confidential draft0000950123-24-012178

Odyssey Therapeutics Inc IPO — frequently asked questions

When did Odyssey Therapeutics Inc go public?: Odyssey Therapeutics Inc completed its IPO on May 8, 2026 on NASDAQ Capital under the ticker ODTX and now trades publicly.
What was Odyssey Therapeutics Inc's IPO price?: Odyssey Therapeutics Inc priced its IPO at $18.00 per share.
Can I buy Odyssey Therapeutics Inc stock?: Yes — Odyssey Therapeutics Inc is publicly traded on NASDAQ Capital as ODTX. You can follow its live price, valuation and post-IPO performance above.
What is Odyssey Therapeutics Inc's valuation?: Odyssey Therapeutics Inc's most recent valuation tracked here is $1.03B, derived from live market prices.